These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 13884584)

  • 1. [Clinicoexperimental investigations with oxyphenylbutazone in otorhinolaryngology].
    DE VINCENTIIS I; CROCE G; SIMONCELLI C
    Boll Mal Orecch Gola Naso; 1962; 80():160-73. PubMed ID: 13884584
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with oxyphenylbutazone in otorhinolaryngoiatric practice].
    RIZZI N
    Gazz Med Ital; 1962 Jan; 121():18-21. PubMed ID: 14492634
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the use and antiphlogistic therapeutic effectiveness of a metabolite of phenylbutazone in some disease processes of otorhinolaryngoiatric interest].
    PAROLARI P
    Otorinolaringol Ital; 1961 Dec; 30():462-6. PubMed ID: 14484015
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the action of a new anti-inflammatory agent G 27202 in otorhinolaryngology].
    ROSSERT A
    Gaz Med Fr; 1961 Sep; 68():1927-31. PubMed ID: 13743681
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of oxyphenylbutazone in some dermatoses].
    PALMINTERI G
    Riforma Med; 1962 May; 76():521-3. PubMed ID: 14483432
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience in the use of Tanderil in otorhinolaryngology].
    FUKUDA E; TOMURA T; TAIRA H
    Jibiinkoka; 1962 Sep; 34():787-9. PubMed ID: 13960165
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oxyphenylbutazone in the therapy of aspecific orchi-epididymitis].
    PADOVAN Q
    Arcisp S Anna Ferrara; 1962; 15():37-43. PubMed ID: 14483103
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience in treatment with the antipyretic drug Tanderil in otorhinolaryngology].
    NAKAMURA F; MIZUGOSHI O; ODA M; KONO Y; SUGAHARA M; NAKAMURA A; YAMASHITA M; IMURA H
    Jibiinkoka; 1962 Sep; 34():791-5. PubMed ID: 13937384
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of a new anti-inflammatory drug in the ORL and maxillofacial domains].
    VINCENT P
    Toulouse Med; 1962 Feb; 63():153-62. PubMed ID: 13926084
    [No Abstract]   [Full Text] [Related]  

  • 10. [Stability of the serum glutamic oxalacetic and glutamic pyruvic transaminases in the course of treatment with oxyphenylbutazone].
    CONCONI F; MATTIOLI G
    Minerva Med; 1962 Jun; 53():1828-30. PubMed ID: 13880804
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oxyphenylbutazone in the prevention of preoperative and postoperative gynecological inflammatory diseases].
    POZZI V; MAZZA A
    Clin Ostet Ginecol; 1962 Mar; 64():129-34. PubMed ID: 14488424
    [No Abstract]   [Full Text] [Related]  

  • 12. A method of drug evaluation in rheumatoid arthritis: results with phenylbutazone, oxyphenylbutazone, cortisone, and prednisone.
    SMYTH CJ
    Ann N Y Acad Sci; 1960 Mar; 86():292-306. PubMed ID: 13832236
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxyphenbutazone ("Tanderil", G 27202): an antirheumatic derivative of phenylbutazone.
    KELLY M
    Med J Aust; 1961 Jun; 48(1)():851-3. PubMed ID: 13752388
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of oxyphenylbutazone (G-27202) in the prevention of postoperative complications in O.R.L. surgerv].
    CATALANO GB; ROSSI M
    Clin Otorinolaringoiatr; 1960; 12():383-90. PubMed ID: 13691516
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of oxyphenbutazone (Tanderil) in obstetrics and gynecology].
    TAKEUCHI H
    Rinsho Fujinka Sanka; 1962 Aug; 16():601-6. PubMed ID: 13919245
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with oxyphenbutazone in the treatment of inflammation and edema.
    MILLER JM; GINSBERG M; ARCE SQ; BOGOSIAN A; SMITH LB
    Antibiotic Med Clin Ther (New York); 1960 Feb; 7():109-14. PubMed ID: 14422539
    [No Abstract]   [Full Text] [Related]  

  • 17. [A simple and precise method for the analysis of phenylbutazone and oxyphenylbutazone by bromocoulometry].
    Nikolic KI; Velasevic KR; Ruasse MF
    Ann Pharm Fr; 1985; 43(2):173-6. PubMed ID: 4091460
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxyphenbutazone ("Tanderil") in rheumatic disease.
    ROBINSON RG
    Med J Aust; 1962 Jul; 49(2)():49-51. PubMed ID: 14492941
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of oxyphenbutazone on pain related to vascular disease.
    STEIN ID
    Ann N Y Acad Sci; 1960 Mar; 86():307-10. PubMed ID: 13834112
    [No Abstract]   [Full Text] [Related]  

  • 20. [Granulocytopenia following oxyphenbutazone treatment].
    HAUGEN J; SKARSTEN KW
    Nord Med; 1962 Aug; 68():1034-5. PubMed ID: 13905395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.